Clinical Trials Browser

Active not recruiting × Sarcoma × Imatinib Mesylate × Clear all

NCT02413736 2025-03-12

Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST

Phase 3 Active not recruiting

Sarcoma